Role of Topical Oxytocin Gel in Post-Menopausal Women

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Menopause Related Conditions
Interventions
OTHER

oxytocin gel

The active oxytocin gel (A) consisted of oxytocin dissolved in a gel-based on hypromellose with a pH of 3.8. 1 ml of gel contained 600 IU of oxytocin

OTHER

placebo gel

The placebo gel (B) consisted of the gel alone

Trial Locations (1)

Unknown

Al-Galaa Teaching Hospital, Cairo

All Listed Sponsors
collaborator

National Research Centre, Egypt

OTHER

lead

Al-Azhar University

OTHER

NCT05275270 - Role of Topical Oxytocin Gel in Post-Menopausal Women | Biotech Hunter | Biotech Hunter